Aardvark Therapeutics (NASDAQ:AARD) Downgraded to Sell Rating by Wall Street Zen
Wall Street Zen cut shares of Aardvark Therapeutics (NASDAQ:AARD – Free Report) from a hold rating to a sell rating in a report published on Saturday. A number of other analysts have also recently weighed in on the stock. Royal Bank of Canada decreased their price target on shares of Aardvark Therapeutics from $21.00 to […]
Wall Street Zen cut shares of Aardvark Therapeutics (NASDAQ:AARD – Free Report) from a hold rating to a sell rating in a report published on Saturday. A number of other analysts have also recently weighed in on the stock. Royal Bank of Canada decreased their price target on shares of Aardvark Therapeutics from $21.00 to […]
